Literature DB >> 11587483

Mucosal uptake of gabapentin (neurontin) vs. pregabalin in the small intestine.

N Piyapolrungroj1, C Li, H Bockbrader, G Liu, D Fleisher.   

Abstract

PURPOSE: To compare the mucosal membrane transport of gabapentin and pregabalin in animal small intestine.
METHODS: Uptake of the two drugs by brush-border membrane vesicles (BBMV) from rat and rabbit small intestine was studied as a function of temperature, uptake-medium sodium content, and intestinal region. Amino acid inhibition studies were conducted with pregabalin.
RESULTS: Gabapentin uptake by rat and rabbit jejunal BBMV was sodium independent, whereas pregabalin uptake was sodium dependent. Uptake of both drugs in rabbit small intestinal vesicles was greater at 25 degrees C than at 4 degrees C in the absence of sodium and an additional increase in uptake was observed for pregabalin at 25 degrees C in the presence of sodium. Pregabalin uptake in rabbit duodenal, jejunal, and ileal BBMV was equivalent, whereas gabapentin uptake was greater in duodenal and ileal BBMV, compared with jejunal BBMV. Although inhibition is weak, a decrease in BBMV uptake of pregabalin is observed with coincubation of high concentrations of both neutral and basic amino acids.
CONCLUSIONS: Amino acid carriers mediate the apical uptake of both drugs in the small intestine. Although gabapentin and pregabalin are structurally similar, their small intestinal mucosal uptake differs in sodium dependence and region dependence. Gabapentin uptake is likely mediated by system b0,+, whereas pregabalin uptake is also mediated by B0 and/or B0,+.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587483     DOI: 10.1023/a:1010970809090

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Transport of pregabalin in rat intestine and Caco-2 monolayers.

Authors:  N Jezyk; C Li; B H Stewart; X Wu; H N Bockbrader; D Fleisher
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.

Authors:  D P Rajan; R Kekuda; W Huang; L D Devoe; F H Leibach; P D Prasad; V Ganapathy
Journal:  Biochim Biophys Acta       Date:  2000-01-15

3.  Variation in amino acid transport along the rabbit small intestine. Mutual jejunal carriers of leucine and lysine.

Authors:  L K Munck; B G Munck
Journal:  Biochim Biophys Acta       Date:  1992-04-22

4.  Transport of N(G)-nitro-L-arginine across intestinal brush border membranes by Na+ -dependent and Na+-independent amino acid transporters.

Authors:  T Hatanaka; Y Nabuchi; H Ushio
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.

Authors:  G Rossier; C Meier; C Bauch; V Summa; B Sordat; F Verrey; L C Kühn
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

6.  Characterization of L-leucine transport system in brush border membranes from human and rabbit small intestine.

Authors:  P Iannoli; J H Miller; H T Wang; B Bode; W W Souba; N E Avissar; H C Sax
Journal:  Metabolism       Date:  1999-11       Impact factor: 8.694

7.  Saturable transport of gabapentin at the blood-brain barrier.

Authors:  M S Luer; C Hamani; M Dujovny; B Gidal; M Cwik; K Deyo; J H Fischer
Journal:  Neurol Res       Date:  1999-09       Impact factor: 2.448

Review 8.  3-substituted GABA analogs with central nervous system activity: a review.

Authors:  J S Bryans; D J Wustrow
Journal:  Med Res Rev       Date:  1999-03       Impact factor: 12.944

9.  Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

Authors:  K O Vollmer; A von Hodenberg; E U Kölle
Journal:  Arzneimittelforschung       Date:  1986-05

10.  A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

Authors:  B H Stewart; A R Kugler; P R Thompson; H N Bockbrader
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

View more
  14 in total

1.  PEPT1 enhances the uptake of gabapentin via trans-stimulation of b0,+ exchange.

Authors:  Theresa V Nguyen; David E Smith; David Fleisher
Journal:  Pharm Res       Date:  2006-12-28       Impact factor: 4.200

Review 2.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

Review 3.  Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.

Authors:  Cory Toth
Journal:  Ther Adv Drug Saf       Date:  2014-02

Review 4.  A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.

Authors:  Howard N Bockbrader; David Wesche; Raymond Miller; Sunny Chapel; Nancy Janiczek; Paula Burger
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447

5.  In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport.

Authors:  Malte Selch Larsen; Sidsel Frølund; Martha Kampp Nøhr; Carsten Uhd Nielsen; Mats Garmer; Mads Kreilgaard; René Holm
Journal:  Pharm Res       Date:  2014-09-03       Impact factor: 4.200

6.  Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.

Authors:  Emily L Abbot; Danielle S Grenade; David J Kennedy; Kelly M Gatfield; David T Thwaites
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  In vivo effects of glycyl-glutamate and glycyl-sarcosine on gabapentin oral absorption in rat.

Authors:  Theresa V Nguyen; David Fleisher; David E Smith
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

Review 8.  Pregabalin for neuropathic pain based on recent clinical trials.

Authors:  Brett R Stacey; Jon N Swift
Journal:  Curr Pain Headache Rep       Date:  2006-06

9.  PREGABALIN TREATMENT OF PERIPHERAL NERVE DAMAGE IN A MURINE DIABETIC PERIPHERAL NEUROPATHY MODEL.

Authors:  J Li; X Chen; X Lu; C Zhang; Q Shi; L Feng
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

10.  Pregabalin for the management of partial epilepsy.

Authors:  Philippe Ryvlin; Emilio Perucca; Sylvain Rheims
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.